Literature DB >> 29462710

Fibrin glue mesh fixation combined with mesenchymal stem cells or exosomes modulates the inflammatory reaction in a murine model of incisional hernia.

Rebeca Blázquez1, Francisco Miguel Sánchez-Margallo1, Verónica Álvarez2, Alejandra Usón2, Federica Marinaro2, Javier G Casado3.   

Abstract

Surgical meshes are effective and frequently used to reinforce soft tissues. Fibrin glue (FG) has been widely used for mesh fixation and is also considered an optimal vehicle for stem cell delivery. The aim of this preclinical study was to evaluate the therapeutic effect of MSCs and their exosomes combined with FG for the treatment of incisional hernia. A murine incisional hernia model was used to implant surgical meshes and different treatments with FG, MSCs and exo-MSCs were applied. The implanted meshes were evaluated at day 7 by anatomopathology, cellular analysis of infiltrating leukocytes and gene expression analysis of TH1/TH2 cytokines, MMPs, TIMPs and collagens. Our results demonstrated a significant increase of anti-inflammatory M2 macrophages and TH2 cytokines when MSCs or exo-MSCs were used. Moreover, the analysis of MMPs, TIMPs and collagen exerted significant differences in the extracellular matrix and in the remodeling process. Our in vivo study suggests that the fixation of surgical meshes with FG and MSCs or exo-MSCs will have a beneficial effect for the treatment of incisional hernia in terms of improved outcomes of damaged tissue, and especially, in the modulation of inflammatory responses towards a less aggressive and pro-regenerative profile. STATEMENT OF SIGNIFICANCE: The implantation of surgical meshes is the standard procedure to reinforce tissue defects such as hernias. However, an exacerbated and persistent inflammatory response secondary to this implantation is frequently observed, leading to a strong discomfort and chronic pain in the patients. In many cases, an additional surgical intervention is needed to remove the mesh. This study shows that mesenchymal stem cells and their exosomes, combined with a fibrin sealant, can be used for the successful fixation of these meshes. This new therapeutic approach, assayed in a murine model of incisional hernia, favors the modulation of the inflammatory response towards a less aggressive and pro-regenerative profile.
Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Exosomes; Fibrin glue; Mesenchymal stem cells; Murine model; Surgical meshes

Mesh:

Substances:

Year:  2018        PMID: 29462710     DOI: 10.1016/j.actbio.2018.02.014

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  8 in total

Review 1.  Exosomes in perspective: a potential surrogate for stem cell therapy.

Authors:  Ke Ren
Journal:  Odontology       Date:  2018-10-15       Impact factor: 2.634

Review 2.  Behind the Scenes of Extracellular Vesicle Therapy for Skin Injuries and Disorders.

Authors:  Bibi S Subhan; Michelle Ki; Alexandra Verzella; Shruthi Shankar; Piul S Rabbani
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-12-30       Impact factor: 4.947

3.  Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration.

Authors:  Meadhbh Á Brennan; Pierre Layrolle; David J Mooney
Journal:  Adv Funct Mater       Date:  2020-03-11       Impact factor: 18.808

Review 4.  Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.

Authors:  Tianjiao Geng; Patrick Pan; Euphemia Leung; Qi Chen; Larry Chamley; Zimei Wu
Journal:  Pharm Res       Date:  2021-02-18       Impact factor: 4.200

Review 5.  Exosomal targeting and its potential clinical application.

Authors:  Jiao He; Weihong Ren; Wei Wang; Wenyan Han; Lu Jiang; Dai Zhang; Mengqi Guo
Journal:  Drug Deliv Transl Res       Date:  2022-01-01       Impact factor: 5.671

Review 6.  Extracellular vesicles derived from mesenchymal stem cells: A platform that can be engineered.

Authors:  Bo Qin; Qi Zhang; Dan Chen; Hai-Yang Yu; Ai-Xiang Luo; Liang-Peng Suo; Yan Cai; De-Yang Cai; Jia Luo; Ju-Fang Huang; Kun Xiong
Journal:  Histol Histopathol       Date:  2021-01-05       Impact factor: 2.303

Review 7.  Bioprocessing of Mesenchymal Stem Cells and Their Derivatives: Toward Cell-Free Therapeutics.

Authors:  Jolene Phelps; Amir Sanati-Nezhad; Mark Ungrin; Neil A Duncan; Arindom Sen
Journal:  Stem Cells Int       Date:  2018-09-12       Impact factor: 5.443

8.  A Fibrin Coating Method of Polypropylene Meshes Enables the Adhesion of Menstrual Blood-Derived Mesenchymal Stromal Cells: A New Delivery Strategy for Stem Cell-Based Therapies.

Authors:  Federica Marinaro; Joana M Silva; Alexandre A Barros; Ivo M Aroso; Juan C Gómez-Blanco; Isaac Jardin; Jose J Lopez; María Pulido; María Ángeles de Pedro; Rui L Reis; Francisco Miguel Sánchez-Margallo; Javier G Casado; Esther López
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.